Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using ConcentrationâQTc Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1161
Abstract: Deutetrabenazine (Austedo) is indicated in adults for chorea associated with Huntington disease and tardive dyskinesia. Escalating deutetrabenazine doses were administered to healthy volunteers who were cytochrome P450 2D6 extensive/intermediate metabolizers (EMs) or poor metabolizers (PMs)… read more here.
Keywords: evaluation; qtc analysis; deutetrabenazine; using concentration ... See more keywords